Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
Shinji Tamura, Iichiro Shimomura
Shinji Tamura, Iichiro Shimomura
Published May 2, 2005
Citation Information: J Clin Invest. 2005;115(5):1139-1142. https://doi.org/10.1172/JCI24930.
View: Text | PDF
Commentary Article has an altmetric score of 12

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a component of the metabolic syndrome, with a clinical spectrum ranging from simple fatty liver to steatohepatitis, cirrhosis, and hepatocellular carcinoma. The primary event of NAFLD is the accumulation of triacylglycerols (TAGs) in hepatocytes. In this issue of the JCI, Donnelly et al. report on their use of stable isotope methodology to show that fatty acids stored in adipose tissue and fatty acids newly made within the liver through de novo lipogenesis are the major sources of TAGs in the liver and are secreted as lipoproteins in NAFLD.

Authors

Shinji Tamura, Iichiro Shimomura

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 Total
Citations: 2 8 5 10 10 8 5 3 5 5 5 8 6 2 1 4 5 3 3 98
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (98)

Title and authors Publication Year
Dexamethasone synergizes with high-fat diet to increase lipid deposition in adipocytes
Su M, Wang Y, Yan Z, Luo J, Yang J, Ye H, Liu A, Yang J
The Korean Journal of Internal Medicine 2025
Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice
Ivashkevich D, Ponomarenko A, Manzhulo I, Egoraeva A, Dyuizen I
Pathophysiology 2025
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.
Jung I, Koo DJ, Lee WY
Diabetes & Metabolism Journal 2024
Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Sohouli MH, Tavakoli S, Reis MG, Hekmatdoost A, Guimarães NS
Nutrition & Metabolism 2024
Lactobacillus rhamnosus 069 and Lactobacillus brevis 031: Unraveling Strain-Specific Pathways for Modulating Lipid Metabolism and Attenuating High-Fat-Diet-Induced Obesity in Mice
Ho PY, Chou YC, Koh YC, Lin WS, Chen WJ, Tseng AL, Gung CL, Wei YS, Pan MH
ACS Omega 2024
Effects of Dietary Lipid Levels on the Growth, Muscle Fatty Acid and Amino Acid Composition, Antioxidant Capacity, and Lipid Deposition in Mirror Carp (Cyprinus carpio)
Jiang X, Song Z, Li C, Hu X, Ge Y, Cheng L, Shi X, Jia Z
Animals : an Open Access Journal from MDPI 2024
Elevated Alanine Transaminase-to-Platelet Index (APRI) Is Associated with Obesity and Distinct Forms of Dyslipidemia: A Retrospective Cross-Sectional Study
Alshuweishi Y, Alfayez D, Almufarrih AA, Abudawood A, Alyami H, Alshuweishi FA, Al-Sheikh YA, Alfhili MA
Journal of Clinical Medicine 2024
Liver proteomics identifies a disconnect between proteins associated with de novo lipogenesis and triglyceride storage
Small L, Nguyen TV, Larance M, Saunders DN, Hoy AJ, Schmitz-Peiffer C, Cooney GJ, Brandon AE
Journal of Lipid Research 2024
Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Presenting with Transient Severe Fatty Liver and Subsequent Liver Dysfunction
Suzuki T, Orime K, Akamatsu R, Akiyama T, Yamakawa T, Terauchi Y
Internal Medicine 2024
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
Mucinski JM, Salvador AF, Moore MP, Fordham TM, Anderson JM, Shryack G, Cunningham R, Lastra G, Gaballah AH, Diaz-Arias A, Ibdah JA, Rector RS, Parks EJ
Journal of hepatology 2024
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
Kotlyarov S
World Journal of Gastroenterology 2023
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Odriozola A, Santos-Laso A, Del Barrio M, Cabezas J, Iruzubieta P, Arias-Loste MT, Rivas C, Duque JCR, Antón Á, Fábrega E, Crespo J
International journal of molecular sciences 2023
Gender Differences in the Risk for Incident Non-Alcoholic Fatty Liver Disease According to the Transition of Abdominal Obesity Status: A 16-Year Cohort Study.
Lee JH, Jeon S, Lee HS, Kwon YJ
Nutrients 2023
The role of lipid metabolism in osteoporosis: Clinical implication and cellular mechanism
Zhang J, Hu W, Zou Z, Li Y, Kang F, Li J, Dong S
Genes & Diseases 2023
Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment
Noda S, Harai N, Komai S, Inukai T, Watanabe T, Hosokawa T, Antoku A, Muroi Y, Hayashida R, Okuma H, Suzuki Y, Tsuchiya K
Diabetology International 2023
Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
J Moreno-Vedia, J Girona, D Ibarretxe, L Masana, R Rodríguez-Calvo
Biomedicines 2022
Macrophage functional diversity in NAFLD - more than inflammation.
Barreby E, Chen P, Aouadi M
Nature reviews. Endocrinology 2022
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis.
Murakami K, Sasaki Y, Asahiyama M, Yano W, Takizawa T, Kamiya W, Matsumura Y, Anai M, Osawa T, Fruchart JC, Fruchart-Najib J, Aburatani H, Sakai J, Kodama T, Tanaka T
Cells 2022
Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia.
Mela V, Ruiz-Limón P, Balongo M, Motahari Rad H, Subiri-Verdugo A, Gonzalez-Jimenez A, Soler R, Ocaña L, El Azzouzi H, Tinahones FJ, Valdivielso P, Murri M
The Journal of clinical endocrinology and metabolism 2022
Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity
Leone A, Bertoli S, Bedogni G, Vignati L, Pellizzari M, Battezzati A
Nutrients 2022
Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
Song J, Baek IJ, Park S, Oh J, Kim D, Song K, Kim MK, Lee HW, Jang BK, Jin EJ
iScience 2022
A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
Young EN, Dogan M, Watkins C, Bajwa A, Eason JD, Kuscu C, Kuscu C
International journal of molecular sciences 2022
Lotus (Nelumbo nucifera Gaertn.) Leaf-Fermentation Supernatant Inhibits Adipogenesis in 3T3-L1 Preadipocytes and Suppresses Obesity in High-Fat Diet-Induced Obese Rats.
He Y, Tao Y, Qiu L, Xu W, Huang X, Wei H, Tao X
Nutrients 2022
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Lee KC, Wu PS, Lin HC
Clinical and Molecular Hepatology 2022
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Bashir A, Duseja A, De A, Mehta M, Tiwari P
Liver Research 2022
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies
C von Loeffelholz, SM Coldewey, AL Birkenfeld
Cells 2021
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
S Kotlyarov, A Bulgakov
Cells 2021
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie, Y Yao, T Ye
Frontiers in Cell and Developmental Biology 2021
The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice
V Cossiga, V Lembo, C Nigro, P Mirra, C Miele, V DArgenio, A Leone, G Mazzone, I Veneruso, M Guido, F Beguinot, N Caporaso, F Morisco
Nutrients 2021
Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets
A von Eckardstein, C Binder
2021
Nonalcoholic fatty liver disease stratification by liver lipidomics
Vvedenskaya O, Rose TD, Knittelfelder O, Palladini A, Wodke JA, Schuhmann K, Ackerman JM, Wang Y, Has C, Brosch M, Thangapandi VR, Buch S, Züllig T, Hartler J, Köfeler HC, Röcken C, Coskun Ü, Klipp E, von Schoenfels W, Gross J, Schafmayer C, Hampe J, Pauling JK, Shevchenko A
Journal of lipid research 2021
Effects of Replacement of Dietary Fishmeal by Cottonseed Protein Concentrate on Growth Performance, Liver Health, and Intestinal Histology of Largemouth Bass (Micropterus salmoides)
Liu Y, Lu Q, Xi L, Gong Y, Su J, Han D, Zhang Z, Liu H, Jin J, Yang Y, Zhu X, Xie S
Frontiers in physiology 2021
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
Fukami H, Morinaga J, Nakagami H, Hayashi H, Okadome Y, Matsunaga E, Kadomatsu T, Horiguchi H, Sato M, Sugizaki T, Kuwabara T, Miyata K, Mukoyama M, Morishita R, Oike Y
Cell reports. Medicine 2021
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJ
Hepatology 2021
A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
Nakanishi N, Hashimoto Y, Okamura T, Ohbora A, Kojima T, Hamaguchi M, Fukui M
Scientific Reports 2021
Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms
R Rodríguez-Calvo, S Samino, J Girona, N Martínez-Micaelo, P Ràfols, M García-Altares, S Guaita-Esteruelas, A Junza, M Heras, O Yanes, X Correig, L Masana
Biomolecules 2020
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
JP Mann, M Pietzner, LB Wittemans, ED Rolfe, ND Kerrison, F Imamura, NG Forouhi, E Fauman, ME Allison, JL Griffin, A Koulman, NJ Wareham, C Langenberg
Human Molecular Genetics 2020
The nuclear and cytoplasmic roles of miR-320 in non-alcoholic fatty liver disease
J Zhan, H Lv, B Dai, S Yuan, J Fan, Y Zhao, Z Yin, DW Wang, C Chen, H Li
Aging 2020
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
M Régnier, A Polizzi, S Smati, C Lukowicz, A Fougerat, Y Lippi, E Fouché, F Lasserre, C Naylies, C Bétoulières, V Barquissau, E Mouisel, J Bertrand-Michel, A Batut, TA Saati, C Canlet, M Tremblay-Franco, S Ellero-Simatos, D Langin, C Postic, W Wahli, N Loiseau, H Guillou, A Montagner
Scientific Reports 2020
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
S Francque, G Szabo, MF Abdelmalek, CD Byrne, K Cusi, JF Dufour, M Roden, F Sacks, F Tacke
Nature Reviews Gastroenterology & Hepatology 2020
Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
Maliakkal BJ
Translational Gastroenterology and Hepatology 2020
Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes
WJ Choi, HJ Dong, HU Jeong, DW Ryu, SM Song, YR Kim, HH Jung, TH Kim, YH Kim
Scientific Reports 2020
Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C‐peptide promotes non‐alcoholic fatty liver disease in type 2 diabetes patients
Luo H, Zhao M, Feng X, Gao X, Hong M, Liu M, Li Y, Liu W, Liu Y, Yu C, Cao Y, Yang X, Fang Z, Zhang P
Journal of Diabetes Investigation 2020
Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis: Hepatology Communications
P Tang, HB Low, CW Png, F Torta, JK Kumar, HY Lim, Y Zhou, H Yang, V Angeli, ES Tai, RA Flavell, C Dong, MR Wenk, DY Yang, Y Zhang
Hepatology Communications 2019
Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice
YJ Kim, UJ Jung
International journal of molecular sciences 2019
Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Arase Y, Shiraishi K, Anzai K, Sato H, Teramura E, Tsuruya K, Hirose S, Deguchi R, Toyoda M, Mine T, Kagawa T
Clinical Drug Investigation 2019
PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
Tong L, Wang L, Yao S, Jin L, Yang J, Zhang Y, Ning G, Zhang Z
Cell Death and Disease 2019
RNA-seq analysis of hepatic gene expression of common Pekin, Muscovy, mule and hinny ducks fed ad libitum or overfed
Hérault F, Houée-Bigot M, Baéza E, Bouchez O, Esquerré D, Klopp C, Diot C
BMC Genomics 2019
Molecular pathways of nonalcoholic fatty liver disease development and progression
F Bessone, MV Razori, MG Roma
Cellular and Molecular Life Sciences 2018
Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease
K Cansanção, LS Monteiro, NC Leite, A Dávalos, MT do Carmo, WA Peres
Nutrients 2018
Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line
Rial SA, Ravaut G, Malaret TB, Bergeron KF, Mounier C
2018
Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice
Y Ai, Z Sun, C Peng, L Liu, X Xiao, J Li
Nutrients 2017
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review: Ajmera, Terrault, and Harrison
VH Ajmera, NA Terrault, SA Harrison
Hepatology 2017
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
P Dongiovanni, L Valenti
International journal of molecular sciences 2017
Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, Ståhlman M, Adiels M, Hakkarainen A, Lundbom N, Kilicarslan M, Hallström BM, Lundbom J, Vergès B, Barrett PH, Watts GF, Serlie MJ, Nielsen J, Uhlén M, Smith U, Marschall H, Taskinen M, Boren J
Molecular Systems Biology 2017
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
N Wang, R Kong, H Luo, X Xu, J Lu
PPAR Research 2017
Fatty liver formation in fulminant type 1 diabetes
T Matsuo, Y Ushiroda
Endocrinology, diabetes & metabolism case reports 2016
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
A Sanchez-Pareja, S Clément, M Peyrou, L Spahr, F Negro, L Rubbia-Brandt, M Foti
World journal of gastroenterology : WJG 2016
Fatty acid transport proteins: targeting FATP2 as a gatekeeper involved in the transport of exogenous fatty acids
PN Black, C Ahowesso, D Montefusco, N Saini, CC DiRusso
MedChemComm 2016
Effects of exercise training on intrahepatic lipid content in humans
B Brouwers, MK Hesselink, P Schrauwen, VB Schrauwen-Hinderling
Diabetologia 2016
Anthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels?
Chen S, Guo X, Yu S, Zhou Y, Li Z, Sun Y
International journal of environmental research and public health 2016
Liver steatosis in hepatitis C patients
E González-Reimers
World journal of hepatology 2015
Hepatoprotective Effect of Herb Formula KIOM2012H against Nonalcoholic Fatty Liver Disease
H Park, YH Hwang, DG Kim, J Jeon, J Ma
Nutrients 2015
Associations of Insulin Resistance, Inflammation and Liver Synthetic Function with Very Low Density Lipoprotein: The Cardiovascular Health Study
Jiang ZG, de Boer IH, Mackey RH, Jensen MK, Lai M, Robson SC, Tracy R, Kuller LH, Mukamal KJ
Metabolism: clinical and experimental 2015
Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet
Nam M, Choi MS, Jung S, Jung Y, Choi JY, Ryu DH, Hwang GS
Scientific Reports 2015
The Anti-TNF-α Antibody Infliximab Inhibits the Expression of Fat-Transporter-Protein FAT/CD36 in a Selective Hepatic-Radiation Mouse Model
Martius G, Cameron S, Rave-Fränk M, Hess CF, Wolff HA, Malik IA
International journal of molecular sciences 2015
Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice
K Matsusue, D Aibara, R Hayafuchi, K Matsuo, S Takiguchi, FJ Gonzalez, S Yamano
FEBS Letters 2014
Non-alcoholic fatty liver disease: What the clinician needs to know
MV Machado
World journal of gastroenterology : WJG 2014
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?
G Firneisz
World journal of gastroenterology : WJG 2014
Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease
V Khullar, A Dolganiuc, RJ Firpi
World Journal of Transplantation 2014
Nonalcoholic steatohepatitis and insulin resistance in children
M Arata
World journal of diabetes 2014
Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.
Minato T, Tsutsumi M, Tsuchishima M, Hayashi N, Saito T, Matsue Y, Toshikuni N, Arisawa T, George J
Molecular Medicine 2014
Nonalcoholic fatty liver disease and polycystic ovary syndrome
Vassilatou E
World journal of gastroenterology : WJG 2014
A High-Dose Shiitake Mushroom Increases Hepatic Accumulation of Triacylglycerol in Rats Fed a High-Fat Diet: Underlying Mechanism
Handayani D, Meyer BJ, Chen J, Brown SH, Mitchell TW, Huang XF
Nutrients 2014
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
YY Huang, AM Gusdon, S Qu
Lipids in Health and Disease 2013
Fructose as a key player in the development of fatty liver disease
M Basaranoglu, G Basaranoglu, T Sabuncu, H Sentürk
World journal of gastroenterology : WJG 2013
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies
MA McArdle, OM Finucane, RM Connaughton, AM McMorrow, HM Roche
Frontiers in Endocrinology 2013
Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment
B Fruci, S Giuliano, A Mazza, R Malaguarnera, A Belfiore
International journal of molecular sciences 2013
Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective
H Schmilovitz-Weiss, E Hochhauser, M Cohen, Y Chepurko, S Yitzhaki, E Grossman, A Leibowitz, Z Ackerman, Z Ben-Ari
Lipids in Health and Disease 2013
Factors underlying the association of body mass index with serum ALT in Chinese hypertensive adults without known hepatic diseases
Zhang Y, Qin XH, Li JP, Cui YM, Liu ZY, Zhao ZG, Ge JB, Guan DM, Hu J, Wang YN, Zhang FM, Xu X, Xu XP, Huo Y
Journal of Zhejiang University. Science. B 2013
Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance
L Zhu, WC Brown, Q Cai, A Krust, P Chambon, OP McGuinness, JM Stafford
Diabetes 2012
Fructose consumption during pregnancy and lactation induces fatty liver and glucose intolerance in rats
Zou M, Arentson EJ, Teegarden D, Koser SL, Onyskow L, Donkin SS
Nutrition research (New York, N.Y.) 2012
Genetic determinants of hepatic steatosis in man
AJ Hooper, LA Adams, JR Burnett
Journal of lipid research 2011
A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats
M Lu, D Patsouris, P Li, J Flores-Riveros, JM Frincke, S Watkins, S Schenk, JM Olefsky
American journal of physiology. Endocrinology and metabolism 2010
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability
YM Yang, CY Han, YJ Kim, SG Kim
World journal of gastroenterology : WJG 2010
Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
ZX Yang, W Shen, H Sun
Hepatology International 2010
Fatty liver disease in children: eat now pay later
De Bruyne RM, Fitzpatrick E, Dhawan A
Hepatology International 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
High fat feeding induces hepatic fatty acid elongation in mice
MH Oosterveer, TH van Dijk, UJ Tietge, T Boer, R Havinga, F Stellaard, AK Groen, F Kuipers, DJ Reijngoud
PloS one 2009
High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers?
G Boden
Gastroenterology 2009
High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers?
Boden G
Gastroenterology 2009
Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.
Carallo C, Mancuso G, Mauro G, Laghi F, Madafferi B, Irace C, Gnasso A, Scavelli F, Dell'Aquila F, Bartone M, Gullo F, Ferraro M, Spagnuolo V, Belmonte M, Ferrara A, Silvano Rotondaro A, Brandolino N, Parasporo F, Scopelliti F
Journal of Gastroenterology 2009
PPAR-gamma in the endothelium regulates metabolic responses to high fat diet
Takeshi Kanda, Jonathan D. Brown, Gabriela Orasanu, Silke Vogel, Juliano Sartoretto, Thomas Michel, Jorge Plutzky
Journal of Clinical Investigation 2008
Breathing Room: The (Un)Natural History of Adipose Microhypoxia and Insulin Resistance
KD Copps, MF White
Diabetes 2008
Fatty liver, insulin resistance, and dyslipidemia.
Adiels M, Taskinen MR, Borén J
Current Diabetes Reports 2008
Overproduction of large VLDL particles is driven by increased liver fat content in man
M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, J Westerbacka, S Vehkavaara, A Häkkinen, SO Olofsson, H Yki-Järvinen, J Borén
Diabetologia 2006
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O
World Journal of Gastroenterology 2006
Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats
Aller MA, Vara E, García C, Nava MP, Angulo A, Sánchez-Patán F, Calderón A, Vergara P, Arias J
World journal of gastroenterology : WJG 2006

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 2 X users
180 readers on Mendeley
See more details